Skip to main content
OpenTrials
Completed

NCT Number: NCT01292915

Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients

The main aim of the study is to describes the outcomes of patients with Upper Gastrointestinal Bleed (UGIB) in a real-life setting. Additionally analyse assessed predictors of outcome, including the impact of hemostatic endoscopic and pharmacologic therapies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Re-bleeding in NVUGIB

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Da Nang, Vietnam

Loading trial locations.

About this study

MSD

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (>=18yrs) admitted to the hospital, or inpatients admitted for another reason, presenting with overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia...
  • Evidence that an upper GI endoscopy was performed

Exclusion criteria

  • GI bleeding not from NVUGIB

Treatment and study plan

Primary outcomes

  1. Rebleeding (within 7 days from the Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB) episode)

    Time frame: 7 days

Secondary outcomes

  1. Surgery due to re-bleeding

    Time frame: 7 days

  2. Mortality due to bleeding

    Time frame: 7 days

  3. Rebleeding in high risk peptic ulcer patients

    Time frame: 7 days

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: NIS-PUB

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Feb 10, 2011
Registry last updated
May 16, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.